Cellectar Biosciences, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Cellectar Biosciences, Inc. (CLRB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $463.00 thousand for the 12-month period ending 2022-12-31, per its 10-K/A filed 2024-10-29.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-10-29
- Cellectar Biosciences, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $463.00K.
- Cellectar Biosciences, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2014 was $254.02K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2022-12-31 | $463.00K 10-K/A · filed 2024-10-29 |
| 2014-12-31 | $254.02K 10-K/A · filed 2016-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |